¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Timoptic-XE Sterile Ophthalmic Gel Forming Solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cardioplegic solution
    ½ÉÀåÁ¤Áö¾×
  • disclosing solution
    1. Ä¡ÅÂÂø»ö¾× 2. ³ëÃâ¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×
  • hypotonic solution
    ÀúÀå¾×
  • heavy solution
    Áß¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • isotonic solution
    µîÀå¾×
  • Lugol¡¯s solution
    ·ç°ñ¿ë¾×
  • maintenance solution
    À¯Áö¿ë¾×
  • molar solution
    ¸ô¾×
  • normal saline solution
    »ý¸®½Ä¿°¼ö
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • conjugate solution
    ¦¿ë¾×
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • disclosing solution
    Ä¡ÅÂÂø»ö¾×
  • equimolecular solution
    µîºÐÀÚ¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • heavy solution
    Áß¾×
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×, ³ôÀº»ïÅõ¾Ð¿ë¾×
  • hypertonic salt solution
    °íÀå½Ä¿°¼ö
  • hypotonic solution
    ÀúÀå¾×, ³·Àº»ïÅõ¾Ð¿ë¾×
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Hartmann s hypotonic solution
    Çϸ£Æ®¸¸ÀúÀå¾×.
  • Hayem s solution
    ¾ÆÀ̾ä¿ë¾×.
  • Heidenhain s hematoxylin staining solution
    ÇÏÀ̵§ÇÏÀÎ Ç츶Åå½Ç¸° ¿°»ö¾×.
  • Locke s solution
    ·ÎÅ©¾×.
  • Lockes solution
    ·ÎÅ©¾×
  • Lockes solution
    ·ÎÅ©¾×(¡­äû).
  • Lugols solution
    ·ç°ñ¾× (±×¶÷¿°»ö¿ë ¸Å¿°Á¦)
  • Ringer s solution
    ¸µ°Å¾×.
  • Ringers solution
    ¸µ°Å¾×
  • Tyrodes solution
    Ƽ·Îµå¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×(â©åÆäû)
  • aseptic solution
    ¹«±Õ¾×(¡­äû).
  • aseptic solution
    ¹«±Õ¾×(¡­¾×).
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acid forming
    »ê¹ß»ý(ß«Û¡ßæ)ÀÇ.
  • aerobic spore-forming bacilli
    È£±â¼º ¾ÆÆ÷Çü¼º°£±Õ
  • antibody forming cell
    Ç×ü»ý»ê¼¼Æ÷(ù÷ô÷ßæß§á¬øà).
  • band forming pliers
    ´ëȯ¼ºÇü°âÀÚ(¡­à÷û¡ÌÆí­).
  • blood forming organ
    Á¶Ç÷±â°ü(̴̡˻?).
  • blood forming organ
    Á¶Ç÷±â°ü(ðãúìÐïί).
  • burst-forming unit
    ¹ö½ºÆ®Çü¼º ´ÜÀ§
  • cell, plaque-forming
    ÇöóÅ© Çü¼º¼¼Æ÷
  • cell, rosette forming
    ·ÎÁ¦Æ®Çü¼º¼¼Æ÷
  • colony forming cell
    ³»ºÎ Áý¶ôÇü¼º¼¼Æ÷.
  • colony forming unit
    Áý¶ôÇü¼º´ÜÀ§(ó¢Õªû¡à÷Ó¤êÈ)
  • colony forming unit (CFU)
    Áý¶ô¼ö, »ý±Õ¼ö, ¼¼Æ÷±º¼ö
  • colony-forming unit
    Áý¶ôÇü¼º ´ÜÀ§
  • erythroid-forming units
  • focus forming unit
    ¹ÙÀÌ·¯½º Æ÷Ä¿½º Çü¼º´ÜÀ§
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • gradient gel electrophoresis
    ±¸¹è(ÎþÛÕ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • immuno-gel filtration
    ¸é¿ª(Øóæ¹)-Á© ¿©°ú(ÕëΦ)
  • plasma gel
    Á©»ó(ßÓ) ¿øÇüÁú(ê«û¡òõ)
  • polyacrylamide gel
    Æú¸®¾ÆÅ©¸±¾Æ¸¶À̵åÁ©
  • polyacrylamide gel electrophoresis
    Æú¸®¾ÆÅ©¸±¾Æ¸¶À̵åÁ© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • pulsed-field gel electrophoresis
    ÆÞ½ºÀå(íÞ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • resolving gel
    ºÐ¸®(ÝÂ×î)Á©
  • running gel
    ¿µµ¿(ç¶ÔÑ)Á©
  • separation gel
    ºÐ¸®(ÝÂ×î)Á©
  • sequencing gel
    ¼­¿­ºÐ¼®(ßíÖªÝÂà°) Á©
  • silica gel
    ½Ç¸®Ä«Á©
  • sodium dodecyl sulfate polyacrylamide gel electrophoresis
    µµµ¥½Ç Ȳ»ê(üÜß«) ³ªÆ®¸®¿ò Æú¸®¾ÆÅ©¸±¾Æ¸¶À̵å Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • spacer gel
    °£°Ý(Êà̰) Á©
  • stacking gel
    ³óÃà(ÒØõê)Á©
  • starch gel electrophoresis
    ³ì¸»Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
DOMS Diploma in Ophthalmic Medicine and Surgery
NOSTA Naval Ophthalmic Support and Training Activity
NOTB National Ophthalmic Treatment Board
OAP Office of Adolescent Pregnancy; old age pension, old age pensioner; ophthalmic artery pressure; oste...
ODSG ophthalmic Doppler sonogram
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
KRB Krebs Ringer Bicarbonate solution
LR Lactated Ringer solution
LRS Lactated Ringer's Solution
PSS Physiological saline solution
PEG-ELS Polyethylene glycol-electrolyte lavage solution
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lactated Ringer's solution
    À¯»êÀ» °¡ÇÑ ¸µ°Å ¾×
  • Naegeli's solution
    ³×°Ö¸® ¿ë¾×
    È¿¸ð, °õÆÎÀÌ µî¿¡ »ç¿ëÇÏ´Â Àΰø ¹èÁö·Î, ÀÌ¿°±â¼º Àλê Ä®·ý 0.2g, ¿°È­ Ä®½· 0.1g, ÁÖ¼®»ê ¾Ï¸ð´½ 10gÀ» ¹° 1,000cc¿¡ ³ìÀÎ °Í.
  • normal saline solution
    Á¤¼º »ý¸® ½Ä¿°¼ö
  • novocaine solution
    ³ëº¸ÄÉÀÎ ¿ë¾×
  • parenteral solution
    ÁÖ»ç¾×
  • povidone-iodine solution

    powder (ºÐ¸», »êÁ¦

    °íÇüÀÇ ¾à¹°À» °¥°Å³ª ºÎ½¤ ¾òÀº ¼Ò¸³ÀÚÀÇ ÁýÇÕü.
  • ringer's lactate solution
    ¸µ°Å¾×
    tri
  • Ringer's solution
    ¸µ°Å ¾×
  • solid solution
    °í¿ëü
    1. °íü »óÅ¿¡¼­ ¿ë¸Å ¿øÀÚ¿Í ¿ëÁú ¿øÀÚ°¡ ¼­·Î ³ì¾Æ ÀÖ´Â ÇÕ±Ý. 2. ¹°¿¡ ½Ä¿°À» ¼¯¾î¼­ ´ÜÀÏ»óÀÇ ¿ë¾×À» ¸¸µå´Â °Í°ú °°ÀÌ, °íü »óÅ¿¡¼­µµ ÇÑ ±Ý¼Ó¿¡ ´Ù¸¥ ±Ý¼Ó ¶Ç´Â ºñ±Ý¼ÓÀÌ ¼¯¿© µé¾î°¡ ´ÜÀÏ»óÀÇ °íü »óÅÂÀÇ ¿ë¾×À» ¸¸µå´Â °æ¿ì°¡ Àִµ¥ À̰ÍÀÌ °í¿ëüÀÌ´Ù.
  • solution tablet
    ¿ëÇØÁ¤
  • stock solution
    ¿ø¾×
  • strong ammonia solution
    °­ ¾Ï¸ð´Ï¾Æ¼ö
    ¹«»ö Åõ¸íÇÑ °­ ¾ËÄ®¸®¼º ¿ë¾×. 27¡­30%ÀÇ ¾Ï¸ð´Ï¾Æ¸¦ ÇÔÀ¯ÇÑ´Ù. ¿ë¸Å ¹× ¾Ï¸ð´Ï¾Æ¿øÀ¸·Î »ç¿ëµÈ´Ù.
  • supersaturated solution
    °úÆ÷È­ ¾×
    ¿µ±¸È÷ ÇÔÀ¯µÉ ¼ö ÀÖ´Â ¾ç ÀÌ»óÀÇ ¿ëÁúÀÌ ³ì¾Æ ÀÖ´Â ºÒ¾ÈÁ¤ÇÑ ¿ë¾×.
  • thymol solution
    Ƽ¸ô ¿ë¾×
  • toluidine blue solution
    toluidine blue ¿ë¾×
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
gel diffusion reactions Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
gel electrophoresis <molecular biology> Electrophoresis using a gel supporting phase. Usually applied to systems where the gel is based on polyacrylamide.
See: electrophoresis.
(05 May 1997)
gel exclusion chromatography <investigation> A lab technique, a type of column chromatography, used to separate the components of a mixture by molecular size and to collect the molecules which are larger than a certain size. It is similar to gel filtration, small molecules are slowed or trapped by the pores in the gel beads filling the column, while large molecules, too large to fit into the pores, slide past the beads and get to the bottom of the column first. at this point, the large molecules are collected. Gel exclusion refers to the maximum size of molecule which will fit into the gel bead pores, and this lab technique is used to collect the molecules in the mixture which are larger than, or excluded from, the pores.
(09 Oct 1997)
gel filtration <molecular biology> An important method for separating molecules according to molecular size by percolating the solution through beads of solvent permeated polymer that has pores of similar size to the solvent molecules. Unlike a continous filter that retards flow according to molecular size, separation is achieved because molecules that can enter the beads take a longer path (i.e. Are retarded) than those that cannot. Typical gels for protein separation are made from polyacrylamide or from flexible (Sephadex) or rigid (agarose, Sepharose) sugar polymers. The size separation range is determined by the degree of cross linking of the gel.
(05 May 1997)
gel filtration chromatography See: gel filtration.
(05 Mar 2000)
gel retardation assay A lab technique used to find out if there are proteins binding a fragment of DNA (in a DNA-protein complex) by watching how fast the DNA fragment moves through an electric field and seeing whether it moves slower when a particular protein is also present.
(09 Oct 1997)
gel structure Brush heap structure of fibrils giving firmness to hydrocolloids.
(05 Mar 2000)
gel transfer Any lab technique used to transfer substances which had been separated using gel electrophoresis from the gel to a membrane for further processing or analysis. For example: any type of blotting.
(09 Oct 1997)
pharmacopeial gel A suspension, in a water medium, of an insoluble drug in hydrated form wherein the particle size approaches or attains colloidal dimensions.
(05 Mar 2000)
chromatography, gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination.
(12 Dec 1998)
colloidal gel A colloid that has developed resistance to flow because of chemical or thermal change.
(05 Mar 2000)
polyacrilamide gel A white, water-soluble, solid gel used as a gel base for electrophoresisand as a thickening or adhesive additive in other industrialapplications.
(09 Oct 1997)
polyacrylamide gel electrophoresis Analytical and separative technique in which molecules, particularly proteins, are separated by their different electrophoretic mobilities in a hydrated gel.
The gel suppresses convective mixing of the fluid phase through which the electrophoresis takes place and contributes molecular sieving. Commonly carried out in the presence of the anionic detergent sodium dodecylsulphate (SDS).
SDS denatures proteins so that noncovalently associating sub unit polypeptides migrate independently and by binding to the proteins confers a net negative charge roughly proportional to the chain weight.
See: SDS PAGE.
(21 Jun 1999)
pulsed-field gel electrophoresis Gel electrophoresis in which, after electrophoretic migration has begun, the current is briefly stopped and reapplied in a different orientation; allows for the purification of long DNA molecules.
Synonym: pulsed-field gel electrophoresis.
(05 Mar 2000)
pulse-field gel electrophoresis Gel electrophoresis in which, after electrophoretic migration has begun, the current is briefly stopped and reapplied in a different orientation; allows for the purification of long DNA molecules.
Synonym: pulsed-field gel electrophoresis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á